Skip to main content
. 2020 Jul 21;5(1):e000458. doi: 10.1136/bmjophth-2020-000458

Table 2.

Expression levels in ARPE-19 Treated cells with CPFX and TETRA compared with vehicle-treated controls

Symbol Treated cells with CPFX versus vehicle-control*
P value, fold
Treated cells with TETRA versus vehicle-control*
P value, fold
Apoptosis-regulator genes
 BAX 0.002 0.04
1.977±0.03 1.465±0.09
 BCL2-L13 0.014 0.026
1.41±0.02 1.14±0.03
 BCl2 0.061 0.024
1.76±0.04 2.82±0.56
 CASP3 0.246 0.250
1.39±0.09 1.25±0.30
 CASP7 0.003 0.002
1.71±0.02 1.71±0.02
 CASP9 0.013 0.007
2.13±0.19 1.43±0.03
Antioxidant enzymes related genes
 SOD2 0.014 0.048
1.26±0.06 1.27±0.07
 SOD3 0.24 0.041
0.80±0.05 0.41±0.05
 NOX4 0.031 0.045
0.84±0.06 0.37±0.02
 GPX3 0.018 0.249
1.24±0.06 0.69±0.01
Inflammatory pathway genes
 IL-6 0.048 0.001
1.31±0.03 5.11±0.16
 IL-1β 0.86 0.023
0.31±0.05 2.29±0.19
 IL-33 0.047 0.011
0.34±0.04 0.11±0.008
 TGF-α1 0.211 0.014
0.67±0.06 0.41±0.02
 TGF-β1 0.061 0.043
1.003±0.08 0.54±0.02
 TGF-β2 0.410 0.177
0.62±0.04 0.74±0.07

Fold values greater than 1 indicate upregulation of the gene.

Fold values less than 1 indicate downregulation of the gene.

*Are assigned a value of 1.

ARPE-19, human retinal pigment epithelial cells; CPFX, ciprofloxacin; IL-6, interleukin-6; TETRA, tetracycline; TGF-β1, transforming growth factor-β1.